Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada, impact of variant replacement and waning protection during 10-month follow-up.pdf
COVID-19 vaccines and adverse events of special interest, A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.pdf
Cardiac manifestations and outcomes of COVID-19 vaccine-associated myocarditis in the young in the USA, longitudinal results from the Myocarditis After COVID Vaccination (MACiV) multicenter study.pdf